[1] Liu Z,Davidson A.Taming lupus-a new understanding of pathogenesis is leading to clinical advances[J].Nature Med,2012,18(6):871-882. [2] Ardoin SP,Schanberg LE.The management of pediatric systemic lupus erythematosus[J].Nature Clin Pract Rheumatol,2005,1(2):82-92. [3] 周洁清,姜红.儿童系统性红斑狼疮诊断标准及疾病活动程度评估[J].中国实用儿科杂志,2012,27(9):650-653. [4] Biro E,Danko K,Kiss E,et al.Association of systemic and thyroid autoimmune diseases [J].Clin Rheumatol,2006,25(2):240-245. [5] Attout H,Guez S,Durand J,et al.Hypoparathyoidism in systemic lupus erythematosus[J].Joint Bone Spine,2007,74(3):282-284. [6] 胡桂芳,刘新霞,周毅.系统性红斑狼疮血清性激素水平的研究[J].临床荟萃,2008,23(3):174-176. [7] Ruchika G,Debashish D,John M,et al.Pancreatitis in systemic lupus erythematosus-case series from a tertiary care center in South India[J].The Open Rheumatology,2012,6:21-23. [8] Blich M,Rozin A,Edoute Y.Systemic lupus erythematosus and thyroid disease [J].Isr Med Assoc,2004,6(4):218-220. [9] Kaercher KC,Freitas TT,Pedro de CW,et al.Association between systemic lupus erythematosus,rheumatoid arthritis,hyperprolactinemia and thyroid autoantibodies [J].Arch Med Res,2005,36(1):54-58. [10] Ronchezel MV,Len CA,Castro AS,et al.Thyroid function and serum prolactin levels in patients with juvenile systemic lupus erythematosus[J].Pediatr Endocrinol Metab,2001,14(2):165-169. [11] 谈亚英,吴华香.系统性红斑狼疮与甲状腺功能紊乱[J].临床内科杂志,1995,12(3):21-22. [12] Konstadoulakis MM,Kroubouzos G,Toska A,et al.Thyroid autoantibodies in the subsets of lupus erythematosus:correlation with other autoantibodies and thyroid function[J].Thyrology,1993,5(1):1-7. [13] 李丽.系统性红斑狼疮患者甲状腺功能状况分析[J].临床和实验医学杂志,2011,10(4):261-262. [14] 李锋,冯树芳,徐金华,等.SLE患者生长激素和泌乳素对促甲状腺激素释放激素的反应及与下丘-垂体-肾上腺皮质轴间的相互作用[J].临床皮肤科杂志,2002,31(2):77-78. [15] 刘爱武,李春.系统性红斑狼疮住院患者合并甲状腺功能异常临床分析[J].山西医药杂志, 2010, 39(7): 661-663. [16] 阿迪娜·斯拉木,冯云,武丽君,等.系统性红斑狼疮合并甲状腺功能减退症50例临床分析[J].现代生物医学进展,2013,21(13):4144-4146. |